- Published on
Diagnostic Tests – Antihistone Antibodies
1. What are they specific for?
Antihistone antibodies are most strongly associated with drug-induced lupus erythematosus (DILE). They are commonly positive in patients who develop lupus-like symptoms after exposure to certain medications.
High-risk medications include:
Lupus symptoms + chronic drug exposure → antihistone antibodies
2. What is the treatment?
There is no specific immunologic therapy required.
✅ Stop the offending medication
Symptoms usually resolve after drug discontinuation, and long-term organ damage is uncommon compared with idiopathic SLE.
Key distinction
1. What are they specific for?
Antihistone antibodies are most strongly associated with drug-induced lupus erythematosus (DILE). They are commonly positive in patients who develop lupus-like symptoms after exposure to certain medications.
High-risk medications include:
- Procainamide
- Hydralazine
- Phenytoin
- Sulfonamides
- Isoniazid
- Penicillamine
Lupus symptoms + chronic drug exposure → antihistone antibodies
2. What is the treatment?
There is no specific immunologic therapy required.
✅ Stop the offending medication
Symptoms usually resolve after drug discontinuation, and long-term organ damage is uncommon compared with idiopathic SLE.
Key distinction
- Drug-induced lupus → Antihistone antibodies
- Idiopathic SLE → Anti-dsDNA / Anti-Sm antibodies
- Published on
Diagnostic Tests – India Ink Stain (Cryptococcal Meningitis)
1. What is this?
An India ink stain is a microscopic examination of cerebrospinal fluid (CSF) used to detect Cryptococcus neoformans.
This organism has a thick mucopolysaccharide capsule that repels the ink, creating a characteristic clear halo surrounding the yeast against a dark background.
2. When is this the answer
You should choose India ink staining as the best initial diagnostic test when the clinical scenario describes:
CSF findings often show:
AIDS + subacute meningitis → India ink stain
3. What is the most accurate diagnostic test?
The most accurate tests for cryptococcal meningitis are:
These tests are more sensitive than India ink staining and are used to confirm the diagnosis.
Key comparison
1. What is this?
An India ink stain is a microscopic examination of cerebrospinal fluid (CSF) used to detect Cryptococcus neoformans.
This organism has a thick mucopolysaccharide capsule that repels the ink, creating a characteristic clear halo surrounding the yeast against a dark background.
2. When is this the answer
You should choose India ink staining as the best initial diagnostic test when the clinical scenario describes:
- A patient with advanced AIDS (typically CD4 <100 cells />micro;L)
- Fever and headache
- Possible neck stiffness
- A subacute presentation (slower onset and less severe than bacterial meningitis)
CSF findings often show:
- Mild lymphocytic pleocytosis
- CSF protein and white blood cell counts may be normal, which does not exclude cryptococcal meningiti
AIDS + subacute meningitis → India ink stain
3. What is the most accurate diagnostic test?
The most accurate tests for cryptococcal meningitis are:
- Cryptococcal antigen testing (CSF or serum)
- Fungal culture of the CSF
These tests are more sensitive than India ink staining and are used to confirm the diagnosis.
Key comparison
- Best initial test (classic boards) → India ink stain
- Most accurate test → Cryptococcal antigen or fungal culture
- Published on
Diagnostic Tests – Polymerase Chain Reaction (PCR) HIV RNA Viral Load
1. What is this?
The PCR HIV RNA viral load test is a quantitative blood test that measures the amount of HIV RNA circulating in the bloodstream. It directly reflects the level of viral replication and is one of the most important tools for monitoring HIV infection.
2. When this test is mentioned, what should you think of?
When you see PCR HIV RNA viral load, think disease activity and treatment response:
• It is the first parameter to change after starting effective antiretroviral therapy (ART)
• It is also the earliest indicator of treatment failure or nonadherence
• Viral load predicts the rate of CD4 (T-helper cell) decline
• High viral load → rapid disease progression
• Low or undetectable viral load → slower progression and effective therapy
Exam pearl:
Viral load changes before CD4 count does.
3. When do you answer PCR HIV RNA viral load?
You should select PCR HIV RNA viral load testing in the following situations:
• At the time of initial HIV diagnosis
• Every 3–4 months to monitor response to therapy
• When treatment failure is suspected
• When performing HIV resistance (sensitivity) testing, as viral load measurement is required to assess resistance in a failing regimen
High-yield summary
• Best test for monitoring treatment response → PCR HIV RNA viral load
• Best predictor of disease progression → PCR HIV RNA viral load
• Diagnosis of HIV → antibody/antigen testing (not viral load)
1. What is this?
The PCR HIV RNA viral load test is a quantitative blood test that measures the amount of HIV RNA circulating in the bloodstream. It directly reflects the level of viral replication and is one of the most important tools for monitoring HIV infection.
2. When this test is mentioned, what should you think of?
When you see PCR HIV RNA viral load, think disease activity and treatment response:
• It is the first parameter to change after starting effective antiretroviral therapy (ART)
• It is also the earliest indicator of treatment failure or nonadherence
• Viral load predicts the rate of CD4 (T-helper cell) decline
• High viral load → rapid disease progression
• Low or undetectable viral load → slower progression and effective therapy
Exam pearl:
Viral load changes before CD4 count does.
3. When do you answer PCR HIV RNA viral load?
You should select PCR HIV RNA viral load testing in the following situations:
• At the time of initial HIV diagnosis
• Every 3–4 months to monitor response to therapy
• When treatment failure is suspected
• When performing HIV resistance (sensitivity) testing, as viral load measurement is required to assess resistance in a failing regimen
High-yield summary
• Best test for monitoring treatment response → PCR HIV RNA viral load
• Best predictor of disease progression → PCR HIV RNA viral load
• Diagnosis of HIV → antibody/antigen testing (not viral load)
- Published on
Diagnostic Test – CD4 (T-Cell) Counts
1. What is this?
The CD4 (T-cell) count is a laboratory test used to monitor patients with HIV infection.
It measures the number of CD4⁺ helper T lymphocytes in the blood, which reflects the degree of immune function.
Clinical roles of the CD4 count:
Treatment threshold (classic exam standard):
1. What is this?
The CD4 (T-cell) count is a laboratory test used to monitor patients with HIV infection.
It measures the number of CD4⁺ helper T lymphocytes in the blood, which reflects the degree of immune function.
Clinical roles of the CD4 count:
- Assess severity of immunosuppression
- Determine the need for opportunistic infection prophylaxis
- Monitor response to antiretroviral therapy (ART)
Treatment threshold (classic exam standard):
- Initiate antiretroviral therapy when:
- CD4
- Published on
Emergency and Acute Medicine – Imaging in Abdominal Trauma
Overview
Imaging plays a central role in the evaluation of abdominal trauma and must be guided by the patient’s history, physical examination, and—most importantly—hemodynamic status. Abdominal trauma occurs across a broad spectrum, ranging from isolated abdominal injury to severe multisystem trauma. Injuries are categorized as blunt or penetrating, with penetrating trauma further subdivided into stab wounds and gunshot wounds. Hemodynamic stability is the key determinant in selecting appropriate imaging and procedural strategies. Unstable patients generally require rapid surgical decision-making, whereas many stable patients can be managed nonoperatively with careful imaging and observation.
Clinical Assessment
History should focus on the mechanism of injury, use of restraints, airbags or helmets, prehospital vital signs, mental status at the scene, and any change in mental status. A complete AMPLE history is essential, including allergies (especially to medications or contrast), current medications, past medical and surgical history, last oral intake, and events leading up to the injury.
Physical examination begins with an ABCDE survey (Airway, Breathing, Circulation, Disability, Exposure), followed by full exposure of the patient and careful palpation of all abdominal quadrants. Abdominal injury is identified in only about half of trauma patients, and the physical exam may be unreliable in intoxicated, uncooperative, or multisystem trauma patients.
General Imaging Strategy
All trauma patients are initially managed using the ABCDE approach. Imaging decisions are then tailored according to stability.
Unstable Trauma Patients
Hemodynamically unstable patients should undergo immediate bedside ultrasonography as part of the primary survey. A positive FAST examination strongly suggests intra-abdominal bleeding as the cause of hypotension. A negative FAST raises concern for alternative bleeding sources, including retroperitoneal hemorrhage, pelvic fractures, thoracic bleeding, or significant blood loss prior to arrival. Surgical consultation should be obtained immediately to prepare for definitive operative management.
Stable Trauma Patients
In stable patients, three principal diagnostic modalities are used to define the extent of abdominal injury.
Ultrasound is often the initial screening test. A positive study in a stable patient raises concern for potential deterioration and should prompt rapid CT imaging and surgical consultation.
CT scanning is the definitive diagnostic tool in stable abdominal trauma. It provides superior detection of solid organ and retroperitoneal injuries compared with ultrasound and helps determine whether nonoperative management or interventional radiology techniques, such as embolization, are appropriate. CT is indicated in all stable patients with stab wounds and in patients with gross hematuria to evaluate for renal injury.
Diagnostic peritoneal lavage is now infrequently used, having largely been replaced by ultrasound and CT.
Laboratory Evaluation
Initial laboratory studies include blood type and screen, complete blood count, electrolytes, creatinine, lipase, urinalysis, and electrocardiography when indicated. These tests support imaging findings and assist in identifying associated injuries or complications.
Ultrasound (FAST Examination)
The FAST exam evaluates dependent intraperitoneal spaces where free fluid accumulates, including the hepatorenal recess (Morison pouch), splenorenal space, suprapubic region, and pericardium.
Advantages include rapid bedside performance, noninvasiveness, lack of radiation or contrast, and repeatability during resuscitation.
Limitations include operator dependence and poor sensitivity for solid organ parenchymal injuries, retroperitoneal bleeding, bowel injury, and hemorrhage associated with pelvic fractures.
A positive study is defined by visualization of free fluid or obvious organ injury. Adequate evaluation requires views of the right upper quadrant, left upper quadrant, pelvis, and heart.
Computed Tomography (CT)
CT scanning has a sensitivity of approximately 85–98% for abdominal trauma and provides detailed anatomic information about organ injury. It supports nonoperative management strategies and allows evaluation of the spine and adjacent structures.
Disadvantages include cost, radiation exposure, and the need for intravenous contrast, which carries a risk of allergic reaction and nephrotoxicity. Certain injuries—such as isolated diaphragmatic, pancreatic, or bowel injuries—may be missed early after trauma.
CT is indicated in hemodynamically stable patients and is contraindicated in unstable patients or those who already require emergent laparotomy. Many centers now use a “pan-scan” approach in multisystem trauma, though this increases cumulative radiation exposure.
Angiography
Angiography is useful for identifying and embolizing bleeding vessels, particularly in patients with pelvic fractures or solid organ hemorrhage. It may be used in selected unstable patients when surgical control is not immediately feasible.
Diagnostic Peritoneal Lavage (DPL)
DPL is invasive but highly sensitive for detecting intra-abdominal bleeding, mesenteric injury, and hollow viscus injury. It is now reserved for select situations, such as unstable patients with equivocal ultrasound findings or those requiring emergent surgery for another indication.
A positive test includes aspiration of blood, bile, bowel contents, or urine, or elevated red blood cell counts depending on the mechanism of injury. Contraindications include clear indications for laparotomy, and relative contraindications include prior abdominal surgery, pregnancy, and pediatric patients.
Disposition and Follow-Up
All unstable trauma patients require admission and frequently operative management. Most patients with multisystem trauma and abdominal involvement should be admitted. Pregnant patients beyond 24 weeks’ gestation require hospital admission for fetal–maternal monitoring.
Stable patients may be discharged only after a negative evaluation, sustained hemodynamic stability, and assurance of reliable follow-up and access to emergency care.
Discharge Advice and Safety Netting
Patients discharged after abdominal trauma must be instructed to return immediately for worsening abdominal pain, distention, vomiting, rectal bleeding, or any new concerning symptoms, as intestinal and pancreatic injuries may present late.
Clinical Pearls and Pitfalls
Bedside ultrasound can be performed immediately during resuscitation and repeated if clinical status changes. Increasing reliance on CT has reduced missed injuries but also increased radiation exposure and lifetime cancer risk. Diagnostic peritoneal lavage and local wound exploration are now less commonly used. Common pitfalls include failure to obtain early blood typing and pregnancy testing, and discharging pregnant patients beyond 24 weeks without appropriate monitoring.
Overview
Imaging plays a central role in the evaluation of abdominal trauma and must be guided by the patient’s history, physical examination, and—most importantly—hemodynamic status. Abdominal trauma occurs across a broad spectrum, ranging from isolated abdominal injury to severe multisystem trauma. Injuries are categorized as blunt or penetrating, with penetrating trauma further subdivided into stab wounds and gunshot wounds. Hemodynamic stability is the key determinant in selecting appropriate imaging and procedural strategies. Unstable patients generally require rapid surgical decision-making, whereas many stable patients can be managed nonoperatively with careful imaging and observation.
Clinical Assessment
History should focus on the mechanism of injury, use of restraints, airbags or helmets, prehospital vital signs, mental status at the scene, and any change in mental status. A complete AMPLE history is essential, including allergies (especially to medications or contrast), current medications, past medical and surgical history, last oral intake, and events leading up to the injury.
Physical examination begins with an ABCDE survey (Airway, Breathing, Circulation, Disability, Exposure), followed by full exposure of the patient and careful palpation of all abdominal quadrants. Abdominal injury is identified in only about half of trauma patients, and the physical exam may be unreliable in intoxicated, uncooperative, or multisystem trauma patients.
General Imaging Strategy
All trauma patients are initially managed using the ABCDE approach. Imaging decisions are then tailored according to stability.
Unstable Trauma Patients
Hemodynamically unstable patients should undergo immediate bedside ultrasonography as part of the primary survey. A positive FAST examination strongly suggests intra-abdominal bleeding as the cause of hypotension. A negative FAST raises concern for alternative bleeding sources, including retroperitoneal hemorrhage, pelvic fractures, thoracic bleeding, or significant blood loss prior to arrival. Surgical consultation should be obtained immediately to prepare for definitive operative management.
Stable Trauma Patients
In stable patients, three principal diagnostic modalities are used to define the extent of abdominal injury.
Ultrasound is often the initial screening test. A positive study in a stable patient raises concern for potential deterioration and should prompt rapid CT imaging and surgical consultation.
CT scanning is the definitive diagnostic tool in stable abdominal trauma. It provides superior detection of solid organ and retroperitoneal injuries compared with ultrasound and helps determine whether nonoperative management or interventional radiology techniques, such as embolization, are appropriate. CT is indicated in all stable patients with stab wounds and in patients with gross hematuria to evaluate for renal injury.
Diagnostic peritoneal lavage is now infrequently used, having largely been replaced by ultrasound and CT.
Laboratory Evaluation
Initial laboratory studies include blood type and screen, complete blood count, electrolytes, creatinine, lipase, urinalysis, and electrocardiography when indicated. These tests support imaging findings and assist in identifying associated injuries or complications.
Ultrasound (FAST Examination)
The FAST exam evaluates dependent intraperitoneal spaces where free fluid accumulates, including the hepatorenal recess (Morison pouch), splenorenal space, suprapubic region, and pericardium.
Advantages include rapid bedside performance, noninvasiveness, lack of radiation or contrast, and repeatability during resuscitation.
Limitations include operator dependence and poor sensitivity for solid organ parenchymal injuries, retroperitoneal bleeding, bowel injury, and hemorrhage associated with pelvic fractures.
A positive study is defined by visualization of free fluid or obvious organ injury. Adequate evaluation requires views of the right upper quadrant, left upper quadrant, pelvis, and heart.
Computed Tomography (CT)
CT scanning has a sensitivity of approximately 85–98% for abdominal trauma and provides detailed anatomic information about organ injury. It supports nonoperative management strategies and allows evaluation of the spine and adjacent structures.
Disadvantages include cost, radiation exposure, and the need for intravenous contrast, which carries a risk of allergic reaction and nephrotoxicity. Certain injuries—such as isolated diaphragmatic, pancreatic, or bowel injuries—may be missed early after trauma.
CT is indicated in hemodynamically stable patients and is contraindicated in unstable patients or those who already require emergent laparotomy. Many centers now use a “pan-scan” approach in multisystem trauma, though this increases cumulative radiation exposure.
Angiography
Angiography is useful for identifying and embolizing bleeding vessels, particularly in patients with pelvic fractures or solid organ hemorrhage. It may be used in selected unstable patients when surgical control is not immediately feasible.
Diagnostic Peritoneal Lavage (DPL)
DPL is invasive but highly sensitive for detecting intra-abdominal bleeding, mesenteric injury, and hollow viscus injury. It is now reserved for select situations, such as unstable patients with equivocal ultrasound findings or those requiring emergent surgery for another indication.
A positive test includes aspiration of blood, bile, bowel contents, or urine, or elevated red blood cell counts depending on the mechanism of injury. Contraindications include clear indications for laparotomy, and relative contraindications include prior abdominal surgery, pregnancy, and pediatric patients.
Disposition and Follow-Up
All unstable trauma patients require admission and frequently operative management. Most patients with multisystem trauma and abdominal involvement should be admitted. Pregnant patients beyond 24 weeks’ gestation require hospital admission for fetal–maternal monitoring.
Stable patients may be discharged only after a negative evaluation, sustained hemodynamic stability, and assurance of reliable follow-up and access to emergency care.
Discharge Advice and Safety Netting
Patients discharged after abdominal trauma must be instructed to return immediately for worsening abdominal pain, distention, vomiting, rectal bleeding, or any new concerning symptoms, as intestinal and pancreatic injuries may present late.
Clinical Pearls and Pitfalls
Bedside ultrasound can be performed immediately during resuscitation and repeated if clinical status changes. Increasing reliance on CT has reduced missed injuries but also increased radiation exposure and lifetime cancer risk. Diagnostic peritoneal lavage and local wound exploration are now less commonly used. Common pitfalls include failure to obtain early blood typing and pregnancy testing, and discharging pregnant patients beyond 24 weeks without appropriate monitoring.
- Published on
Emergency and Acute Medicine – Spontaneous Abortion (Early Pregnancy Loss)
Overview and Definitions
Spontaneous abortion refers to the unintentional termination of an intrauterine pregnancy before 20 weeks of gestation. It is also commonly termed early pregnancy loss or miscarriage. This condition occurs in approximately 15–20% of clinically recognized pregnancies, making it the most frequent complication of early pregnancy. Vaginal bleeding during the first trimester is reported in nearly one-quarter of pregnant patients, and about half of these cases ultimately result in pregnancy loss.
Several clinical subtypes are recognized. Threatened abortion presents with vaginal bleeding and a closed cervical os in the presence of a viable intrauterine pregnancy; approximately half of these patients will go on to miscarry. Inevitable abortion is characterized by bleeding with an open cervical os before expulsion of products of conception (POC). Incomplete abortion involves partial expulsion of POC with retained tissue and ongoing bleeding, while complete abortion describes full expulsion of all POC with subsequent closure of the cervical os. Missed abortion occurs when fetal demise is present without uterine activity or expulsion. Septic abortion is complicated by intrauterine infection, and recurrent spontaneous abortion is defined as three or more consecutive pregnancy losses.
Etiology and Risk Factors
The most common cause of spontaneous abortion is fetal chromosomal abnormality. Other contributing factors include uterine structural abnormalities and a variety of maternal risk factors. These include advanced maternal or paternal age, increased parity, smoking, alcohol or cocaine use, conception within a short interval after delivery, and chronic maternal illnesses such as poorly controlled diabetes, autoimmune disease, or celiac disease. Extremes of maternal body mass index, intrauterine devices, multiple prior elective abortions, and prior pregnancy losses also increase risk.
Maternal infections—including bacterial vaginosis, sexually transmitted infections, viral illnesses, parasitic infections, and TORCH pathogens—are important contributors. Certain medications, toxins, and uterine abnormalities such as fibroids, adhesions, or congenital malformations further predispose to pregnancy loss.
Clinical Presentation
Patients commonly present with vaginal bleeding and may report abdominal pain or cramping. Important historical details include last menstrual period, gestational age, obstetric history, prenatal care, and known risk factors. Bleeding should be quantified by duration and number of pads used, and patients should be asked about passage of clots or tissue. Symptoms such as dizziness or syncope may suggest significant blood loss.
Physical Examination
Assessment begins with evaluation of hemodynamic stability. Because blood volume is increased during pregnancy, particularly toward the end of the first trimester, patients may lose a substantial amount of blood before abnormal vital signs appear. Pelvic examination is essential to assess cervical dilation, amount of bleeding, and presence of POC. Adnexal tenderness or signs of peritoneal irritation raise concern for ectopic pregnancy. A bimanual examination helps estimate uterine size, which correlates with gestational age.
Essential Workup
Confirmation of pregnancy and assessment of gestational age and viability are central to evaluation. Imaging and laboratory studies are guided by clinical stability and suspected diagnosis.
Diagnostic Tests and Interpretation
Pregnancy is confirmed with urine or serum testing; most urine tests become positive at low β-hCG levels early in gestation and may remain positive for weeks after pregnancy loss. Laboratory evaluation includes complete blood count, rapid hemoglobin assessment, blood type and Rh status, and quantitative β-hCG levels. Type and cross-match are required for patients with active bleeding or anemia. Any expelled tissue should be sent for pathologic confirmation.
Transvaginal ultrasound is the preferred imaging modality in early pregnancy and can identify a gestational sac by approximately five weeks and cardiac activity by about six and a half weeks. Transabdominal ultrasound detects findings later. The discriminatory β-hCG zone defines the level at which a normal intrauterine pregnancy should be visualized and helps differentiate early pregnancy loss from ectopic pregnancy.
Differential Diagnosis
In patients with a positive pregnancy test and vaginal bleeding, alternative diagnoses include ectopic pregnancy, molar pregnancy, pregnancy of unknown location, cervicitis, subchorionic hemorrhage, septic abortion, and trauma. In later pregnancy, placental abruption and placenta previa must be considered.
Initial Stabilization and Emergency Management
Prehospital and early emergency department care focuses on monitoring vital signs, providing oxygen, establishing intravenous access, and treating hypovolemia. Unstable patients require aggressive resuscitation with large-bore IV access, crystalloid infusion, and transfusion of packed red blood cells if they fail to stabilize. Gynecologic consultation is urgent in unstable patients, as ruptured ectopic pregnancy must always be excluded.
Definitive Management by Clinical Type
Threatened abortion is managed conservatively with pelvic rest and close obstetric follow-up. Patients without documented cardiac activity early in pregnancy require serial β-hCG testing to assess viability and exclude ectopic pregnancy.
Inevitable and incomplete abortions may be managed expectantly, medically with misoprostol, or surgically with dilation and curettage. Surgical management reduces the risk of unplanned admissions and transfusion and allows pathologic confirmation of POC.
Complete abortion typically requires no intervention beyond observation, although uterotonic agents may be used if bleeding persists.
Missed abortion carries a risk of disseminated intravascular coagulation when fetal tissue is retained for several weeks, necessitating laboratory monitoring and specialist follow-up. Management options include expectant, medical, or surgical approaches based on patient preference and clinical stability.
Medications
Rh-negative patients require Rho(D) immunoglobulin to prevent alloimmunization, with dosing based on gestational age. Misoprostol is used for medical management of pregnancy loss under obstetric guidance. Uterotonic agents such as oxytocin or methylergonovine may be required to control heavy bleeding.
Disposition and Follow-Up
Admission is required for suspected ectopic pregnancy, hemodynamic instability, significant anemia, septic abortion, disseminated intravascular coagulation, or suspected gestational trophoblastic disease.
Stable patients may be discharged after appropriate treatment or observation, with pain control and close obstetric follow-up. Clear return precautions are essential.
Discharge Counseling and Support
Patients should be advised to return immediately for worsening bleeding, dizziness, fever, or increasing pain. Pelvic rest is recommended during active bleeding. Emotional support and reassurance are crucial, emphasizing that early pregnancy loss is common and not the result of patient actions.
Clinical Pearls and Pitfalls
Always maintain a high index of suspicion for ectopic pregnancy in early pregnancy bleeding. Significant blood loss can occur despite initially normal vital signs, and careful reassessment is essential.
Overview and Definitions
Spontaneous abortion refers to the unintentional termination of an intrauterine pregnancy before 20 weeks of gestation. It is also commonly termed early pregnancy loss or miscarriage. This condition occurs in approximately 15–20% of clinically recognized pregnancies, making it the most frequent complication of early pregnancy. Vaginal bleeding during the first trimester is reported in nearly one-quarter of pregnant patients, and about half of these cases ultimately result in pregnancy loss.
Several clinical subtypes are recognized. Threatened abortion presents with vaginal bleeding and a closed cervical os in the presence of a viable intrauterine pregnancy; approximately half of these patients will go on to miscarry. Inevitable abortion is characterized by bleeding with an open cervical os before expulsion of products of conception (POC). Incomplete abortion involves partial expulsion of POC with retained tissue and ongoing bleeding, while complete abortion describes full expulsion of all POC with subsequent closure of the cervical os. Missed abortion occurs when fetal demise is present without uterine activity or expulsion. Septic abortion is complicated by intrauterine infection, and recurrent spontaneous abortion is defined as three or more consecutive pregnancy losses.
Etiology and Risk Factors
The most common cause of spontaneous abortion is fetal chromosomal abnormality. Other contributing factors include uterine structural abnormalities and a variety of maternal risk factors. These include advanced maternal or paternal age, increased parity, smoking, alcohol or cocaine use, conception within a short interval after delivery, and chronic maternal illnesses such as poorly controlled diabetes, autoimmune disease, or celiac disease. Extremes of maternal body mass index, intrauterine devices, multiple prior elective abortions, and prior pregnancy losses also increase risk.
Maternal infections—including bacterial vaginosis, sexually transmitted infections, viral illnesses, parasitic infections, and TORCH pathogens—are important contributors. Certain medications, toxins, and uterine abnormalities such as fibroids, adhesions, or congenital malformations further predispose to pregnancy loss.
Clinical Presentation
Patients commonly present with vaginal bleeding and may report abdominal pain or cramping. Important historical details include last menstrual period, gestational age, obstetric history, prenatal care, and known risk factors. Bleeding should be quantified by duration and number of pads used, and patients should be asked about passage of clots or tissue. Symptoms such as dizziness or syncope may suggest significant blood loss.
Physical Examination
Assessment begins with evaluation of hemodynamic stability. Because blood volume is increased during pregnancy, particularly toward the end of the first trimester, patients may lose a substantial amount of blood before abnormal vital signs appear. Pelvic examination is essential to assess cervical dilation, amount of bleeding, and presence of POC. Adnexal tenderness or signs of peritoneal irritation raise concern for ectopic pregnancy. A bimanual examination helps estimate uterine size, which correlates with gestational age.
Essential Workup
Confirmation of pregnancy and assessment of gestational age and viability are central to evaluation. Imaging and laboratory studies are guided by clinical stability and suspected diagnosis.
Diagnostic Tests and Interpretation
Pregnancy is confirmed with urine or serum testing; most urine tests become positive at low β-hCG levels early in gestation and may remain positive for weeks after pregnancy loss. Laboratory evaluation includes complete blood count, rapid hemoglobin assessment, blood type and Rh status, and quantitative β-hCG levels. Type and cross-match are required for patients with active bleeding or anemia. Any expelled tissue should be sent for pathologic confirmation.
Transvaginal ultrasound is the preferred imaging modality in early pregnancy and can identify a gestational sac by approximately five weeks and cardiac activity by about six and a half weeks. Transabdominal ultrasound detects findings later. The discriminatory β-hCG zone defines the level at which a normal intrauterine pregnancy should be visualized and helps differentiate early pregnancy loss from ectopic pregnancy.
Differential Diagnosis
In patients with a positive pregnancy test and vaginal bleeding, alternative diagnoses include ectopic pregnancy, molar pregnancy, pregnancy of unknown location, cervicitis, subchorionic hemorrhage, septic abortion, and trauma. In later pregnancy, placental abruption and placenta previa must be considered.
Initial Stabilization and Emergency Management
Prehospital and early emergency department care focuses on monitoring vital signs, providing oxygen, establishing intravenous access, and treating hypovolemia. Unstable patients require aggressive resuscitation with large-bore IV access, crystalloid infusion, and transfusion of packed red blood cells if they fail to stabilize. Gynecologic consultation is urgent in unstable patients, as ruptured ectopic pregnancy must always be excluded.
Definitive Management by Clinical Type
Threatened abortion is managed conservatively with pelvic rest and close obstetric follow-up. Patients without documented cardiac activity early in pregnancy require serial β-hCG testing to assess viability and exclude ectopic pregnancy.
Inevitable and incomplete abortions may be managed expectantly, medically with misoprostol, or surgically with dilation and curettage. Surgical management reduces the risk of unplanned admissions and transfusion and allows pathologic confirmation of POC.
Complete abortion typically requires no intervention beyond observation, although uterotonic agents may be used if bleeding persists.
Missed abortion carries a risk of disseminated intravascular coagulation when fetal tissue is retained for several weeks, necessitating laboratory monitoring and specialist follow-up. Management options include expectant, medical, or surgical approaches based on patient preference and clinical stability.
Medications
Rh-negative patients require Rho(D) immunoglobulin to prevent alloimmunization, with dosing based on gestational age. Misoprostol is used for medical management of pregnancy loss under obstetric guidance. Uterotonic agents such as oxytocin or methylergonovine may be required to control heavy bleeding.
Disposition and Follow-Up
Admission is required for suspected ectopic pregnancy, hemodynamic instability, significant anemia, septic abortion, disseminated intravascular coagulation, or suspected gestational trophoblastic disease.
Stable patients may be discharged after appropriate treatment or observation, with pain control and close obstetric follow-up. Clear return precautions are essential.
Discharge Counseling and Support
Patients should be advised to return immediately for worsening bleeding, dizziness, fever, or increasing pain. Pelvic rest is recommended during active bleeding. Emotional support and reassurance are crucial, emphasizing that early pregnancy loss is common and not the result of patient actions.
Clinical Pearls and Pitfalls
Always maintain a high index of suspicion for ectopic pregnancy in early pregnancy bleeding. Significant blood loss can occur despite initially normal vital signs, and careful reassessment is essential.
- Published on
Diagnostic Tests – Rheumatoid Factor (RF)
1. What disease is it associated with?
Rheumatoid factor (RF) is most commonly associated with rheumatoid arthritis (RA). It is present in over 70% of patients with RA, making it a useful supportive test. However, RF is not specific for RA and may also be positive in other autoimmune diseases, chronic infections, and even in some healthy older adults.
2. When do you answer rheumatoid factor?
You should select RF testing when the clinical scenario describes:
Symmetric small-joint inflammatory arthritis with morning stiffness → think rheumatoid arthritis → order rheumatoid factor (often along with anti-CCP antibodies).
1. What disease is it associated with?
Rheumatoid factor (RF) is most commonly associated with rheumatoid arthritis (RA). It is present in over 70% of patients with RA, making it a useful supportive test. However, RF is not specific for RA and may also be positive in other autoimmune diseases, chronic infections, and even in some healthy older adults.
2. When do you answer rheumatoid factor?
You should select RF testing when the clinical scenario describes:
- A woman with symmetric inflammatory arthritis
- Morning stiffness that improves with activity
- Involvement of the wrists, metacarpophalangeal (MCP) joints, and proximal interphalangeal (PIP) joints
- Laboratory evidence of inflammation, such as:
- Elevated ESR
- Synovial fluid WBC count between 2,000 and 20,000 cells/µL (inflammatory range)
Symmetric small-joint inflammatory arthritis with morning stiffness → think rheumatoid arthritis → order rheumatoid factor (often along with anti-CCP antibodies).
- Published on
Diagnostic Tests – Muscle Biopsy
1. For which clinical condition(s) would you use this test?
A muscle biopsy is used to diagnose primary myopathies, particularly when a structural, metabolic, inflammatory, or genetic muscle disorder is suspected. Conditions commonly diagnosed with muscle biopsy include:
2. When do you answer muscle biopsy?
You should choose muscle biopsy when the clinical scenario describes:
Proximal weakness + myalgias + suspected intrinsic muscle disease → Muscle biopsy
3. For which muscle diseases would you
not
answer muscle biopsy?
Despite overlapping symptoms of weakness, muscle biopsy is NOT the correct test in the following situations:
1. For which clinical condition(s) would you use this test?
A muscle biopsy is used to diagnose primary myopathies, particularly when a structural, metabolic, inflammatory, or genetic muscle disorder is suspected. Conditions commonly diagnosed with muscle biopsy include:
- Glycogen storage diseases
- Mitochondrial myopathies
- Dystrophinopathies (e.g., Duchenne and Becker muscular dystrophy)
- Inflammatory myopathies, such as dermatomyositis and polymyositis
2. When do you answer muscle biopsy?
You should choose muscle biopsy when the clinical scenario describes:
- Proximal muscle weakness, such as:
- Difficulty with shoulder abduction
- Trouble rising from a chair
- Associated myalgias (muscle soreness)
- Evidence of myopathy, such as:
- Elevated muscle enzymes
- Recurrent rhabdomyolysis
- A possible family history of similar symptoms, suggesting an inherited muscle disorder
Proximal weakness + myalgias + suspected intrinsic muscle disease → Muscle biopsy
3. For which muscle diseases would you
not
answer muscle biopsy?
Despite overlapping symptoms of weakness, muscle biopsy is NOT the correct test in the following situations:
- Endocrine-related myopathies
- Examples: thyroid disease, diabetes
- Appropriate tests: specific endocrine laboratory testing
- Neuromuscular junction disorders
- Example: myasthenia gravis
- Appropriate tests:
- Edrophonium (Tensilon) testing
- Anti–acetylcholine receptor antibodies
- Electromyography (EMG)
- Muscle fiber disease → muscle biopsy
- Endocrine or neuromuscular junction disease → targeted labs or electrophysiologic testing
- Published on
Diagnostic Tests – DEXA Scanning (Dual-Energy X-ray Absorptiometry)
1. What does it show?
A DEXA scan measures bone mineral density (BMD) and is the standard test used to diagnose osteoporosis. It compares a patient’s bone density to that of a healthy young adult population and reports results as T-scores, allowing assessment of fracture risk and bone loss severity.
2. When do you answer a DEXA scan?
You should select DEXA scanning when evaluating patients at high risk for osteoporosis, including:
Exam pearl:
Any condition causing increased bone resorption or decreased bone formation → think DEXA scan.
3. What is the treatment?
Management of osteoporosis includes:
1. What does it show?
A DEXA scan measures bone mineral density (BMD) and is the standard test used to diagnose osteoporosis. It compares a patient’s bone density to that of a healthy young adult population and reports results as T-scores, allowing assessment of fracture risk and bone loss severity.
2. When do you answer a DEXA scan?
You should select DEXA scanning when evaluating patients at high risk for osteoporosis, including:
- Postmenopausal women
- Patients with high cortisol states, such as:
- Cushing’s syndrome
- Chronic exogenous steroid use
- Patients with hyperthyroidism
- Patients with hyperparathyroidism
Exam pearl:
Any condition causing increased bone resorption or decreased bone formation → think DEXA scan.
3. What is the treatment?
Management of osteoporosis includes:
- Estrogen therapy (selected postmenopausal patients)
- Bisphosphonates (first-line therapy for most patients)
- Selective estrogen receptor modulators (SERMs) such as:
- Raloxifene
- TamoxifeN
- Published on
Diagnostic Tests-ANA, Anti–Double-Stranded DNA (anti-dsDNA), and Anti-Smith (anti-Sm) Antibodies
1.
What diseases are they associated with?
- ANA (Antinuclear Antibody)
- More than 98% sensitive for systemic lupus erythematosus (SLE)
- Not specific for SLE (can be positive in other autoimmune diseases and even in healthy individuals)
- A negative ANA essentially excludes SLE, with about a 98% negative predictive value
- Anti–double-stranded DNA (anti-dsDNA)
- Approximately 99% specific for SLE
- Levels often correlate with disease activity, particularly lupus nephritis
- Anti-Smith (anti-Sm)
- Extremely specific for SLE
- Less sensitive, but when present, it is diagnostic of lupus
2.
When do you answer/order this test?
Answer ANA, anti-dsDNA, and anti-Sm antibodies when the clinical presentation suggests systemic lupus erythematosus, classically:
- Young female with:
- Multiple spontaneous abortions (suggesting lupus anticoagulant / antiphospholipid antibodies)
- Rash (malar or photosensitive)
- Joint pains / inflammatory arthritis
- May also have renal disease, cytopenias, or serositis
- ANA → screening test (rules out SLE if negative)
- Anti-dsDNA & Anti-Sm → confirmatory tests (rule in SLE if positive)
